The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
The American Heart Association found that young, Black adults are more than twice as likely to die in the first year after a heart transplant - in comparison to non-Black transplant recipients of the same age.
Engineers at the University of Bath have published a mathematical model that could help clinicians to safely ventilate two COVID patients on one ventilator.
Data from Queen Mary University of London suggests that Asian COVID patients are 1.5 times as likely to die as white patients - with Black patients 1.3 times more likely to die.
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
A new risk-stratification tool has been developed by researchers from the UK Coronavirus Clinical Characterisation Consortium and can accurately predict the likelihood of deterioration in hospitalised COVID-19 patients.
Here, Mark Clements, MD PhD, paediatric endocrinologist, clinical investigator, and chief medical officer at Glooko Inc. takes part in a Q&A regarding his perspectives on remote clinical trials and data management tools.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.
